Elacridar is a potent P-glycoprotein (P-gp/ABCG1) and breast cancer resistance protein (BCRP) inhibitor . GF120918 increases the bio availability of cytotoxic anti-tumor drugs, and also leads to increased levels of anti-HIV drugs in the brain and CNS

Numéro d'article : BIOV2792-25

Unité de mesure : 25 MG

473.00 CHF 473.0 CHF 473.00 CHF

473.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Numéro CAS : 143664-11-3

Fabricant : BIOVISION

Numéro du fabricant : 2792-25

Formule chimique : C34H33N3O5

Température de stockage : Freezer (-20)

Elacridar is a potent P-glycoprotein (P-gp/ABCG1) and breast cancer resistance protein (BCRP) inhibitor . GF120918 increases the bio availability of cytotoxic anti-tumor drugs, and also leads to increased levels of anti-HIV drugs in the brain and CNS

Elacridar is a potent P-glycoprotein (P-gp/ABCG1) and breast cancer resistance protein (BCRP) inhibitor . GF120918 increases the bio availability of cytotoxic anti-tumor drugs, and also leads to increased levels of anti-HIV drugs in the brain and CNS

473.00 CHF 473.0 CHF 473.00 CHF

473.00 CHF

Not Available For Sale